JPRN-jRCT1032230536招募中2 期
The efficacy and safety of 21-gene assay (Oncotype DX) in neoadjuvant endocrine therapy for postmenopausal breast cancer, single-arm phase II study.
Takei Hiroyuki0 个研究点目标入组 26 人开始时间: 2023年12月25日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- Female
入选标准
- •1. Women with untreated invasive and hormone receptor positive and HER2 negative breast cancer
- •2. Postmenopausal state
- •3. Can be written informed consent
排除标准
- •1. BRCA1/2 variant
- •2. Allergy of hormone therapy or contrast agent
研究者
相似试验
尚未招募
2 期
A study to determine if candidate malaria vaccines are safe, effective, and induce immunity among Kenyan adults.MalariaPACTR202108505632810niversity of Oxford84
招募中
不适用
Evaluation Study for its Clinical Utility of Gene Prognostic Signature MammaPrint for Early-Breast CancerBreast CancerJPRN-UMIN000002834Department of Breast and Endocrine Surjery, Juntendo University School of Medicine50
招募中
不适用
Fine mapping in the Korean schizophrenic familiesMental and behavioral disordersKCT0001655Pusan National University Hospital1,000
招募中
1 期
GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early ResultsAdvanced Solid TumorHead and Neck NeoplasmColorectal CancerPancreatic CancerNon-Small Cell Lung CancerNCT05183243Suzhou Genhouse Bio Co., Ltd.68
进行中（未招募）
1 期
Prospective study on safety and efficacy of gene therapy with voretigene neparvovec (Luxturna®) in patients with RPE65-associated inherited retinal degenerationsEUCTR2021-000265-33-NLThe Rotterdam Eye Hospital20